FDA bans sale of Vuse Alto menthol e-cigarettes, citing health risks for teens

Indonesia Berita Berita

FDA bans sale of Vuse Alto menthol e-cigarettes, citing health risks for teens
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 fox5ny
  • ⏱ Reading Time:
  • 12 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 51%

British American Tobacco (BAT), the parent company of Reynolds said it would challenge the FDA ban in court.

"We believe appropriately regulated flavored vaping products — including menthol — are critical in supporting adult smokers migrate from combustible cigarettes," Kingsley Wheaton, BAT's chief strategy and growth officer, said in a newsThe news follows an alarming statistic released by health officials last year which found that an estimated 2.55 million U.S.

"Adolescent e-cigarette use in the United States remains at concerning levels, and poses a serious public health risk to our nation’s youth," Brian King, director of FDA center for tobacco products said in a statement.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

fox5ny /  🏆 587. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

FDA bans sale of Vuse Alto menthol e-cigarettes, citing health risks for teensFDA bans sale of Vuse Alto menthol e-cigarettes, citing health risks for teensBritish American Tobacco (BAT), the parent company of Reynolds said it would challenge the FDA ban in court.
Baca lebih lajut »

FDA considers banning some hair-straightening products over possible cancer linkFDA considers banning some hair-straightening products over possible cancer linkThe U.S. Food and Drug Administration is considering banning hair straightening and smoothing products with formaldehyde or formaldehyde-causing ingredients.
Baca lebih lajut »

FDA considers banning some hair-straightening products over possible cancer linkFDA considers banning some hair-straightening products over possible cancer linkThe U.S. Food and Drug Administration is considering banning hair straightening and smoothing products with formaldehyde or formaldehyde-causing ingredients.
Baca lebih lajut »

FDA Approves Non-Opioid Post-Op Pain TreatmentThe U.S. health regulator has approved Hyloris Pharmaceuticals' drug for post-operative pain, the Belgium-based company said on Wednesday, adding that it expects to launch the non-opioid treatment in the United States by early next year. The injectable drug, branded as...
Baca lebih lajut »

The FDA Has Proposed a Ban on Hair-Straightening Products Containing FormaldehydeThe FDA Has Proposed a Ban on Hair-Straightening Products Containing FormaldehydeThe FDA just introduced a potential ban on hair-straightening products like relaxers and smoothing treatments containing the carcinogen formaldehyde. Here's what to know.
Baca lebih lajut »

FDA to consider banning an ingredient in hair straightening products claiming cancer linkFDA to consider banning an ingredient in hair straightening products claiming cancer linkThe proposed rule would ban formaldehyde (FA) and other FA-releasing chemicals from being used as an ingredient in hair smoothing or hair straightening products marketed in the United States.
Baca lebih lajut »



Render Time: 2025-02-27 20:17:20